← FDA DRUG APPROVALS

FDA NDA · NDA207963

PALONOSETRON HYDROCHLORIDE

Sponsor: HIKMA

APPLICATION
NDA207963
TYPE
NDA
ORIGINAL APPROVAL
2016-08-22
LATEST ACTION
2016-08-22
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

PALONOSETRON HYDROCHLORIDEDiscontinued
PALONOSETRON HYDROCHLORIDE EQ 0.25MG BASE/2ML (EQ 0.125MG BASE/ML) · SOLUTION · INTRAVENOUS

Approval history

2016-08-22Type 5 - New Formulation or New Manufacturer · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →